Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Post by bayoubuckson Jun 01, 2014 10:43am
472 Views
Post# 22618925

Warrants

WarrantsWhy would anyone want to exercise their warrants when they are good until Nov 2015?  To take a profit?  The only reason I can think of is if they needed the cash for other reasons or thought they could invest it elsewhere for a better return.  It would be great if they are exercising them now which would preclude the company needing to raise additional capital in the near future!   

On November 7, 2013, the Company completed a financing by way of a non-brokered private placement, where 21,000,000 units were issued at a price of $0.15 per unit for gross proceeds of $3,150,000. Each unit consists of 1 common share and 1 non-transferable common share purchase warrant with a four-month holding period. Each whole warrant entitled the holder thereof to acquire 1 common share at a price of $0.20, expiring on November 7, 2015. In connection with the offering, the Company paid certain finders cash commissions totaling $299,675 (10% of referred business), settled commissions through equity issuance in the amount of 43,334 shares at a price of $0.15 per unit for a total of $6,500 and issued an aggregate of 1,985,900 (10% of referred business) finder warrants, each finder warrant exercisable into one common share at an exercise price of $0.20 per share for a period of 24 months after the closing of the offering. There was a total share issue cost of $20,470.

Bullboard Posts